This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $246,521 to The Trustees of Columbia University in the City of New York to implement a workforce development program. The program aims to train public health and clinical research professionals in West Africa on using genetic, molecular, and serological approaches for pan-pathogen surveillance, as well as...
The Centers for Disease Control and Prevention (CDC) awarded a $799,904 Cooperative Agreement to New York University School of Medicine under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The award, which runs from September 30, 2024 to September 29, 2029, supports activities to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases. Key products and services to be delivered include...
The Puerto Rico Department of Health (PRDOH) was awarded a $4,639,996 Cooperative Agreement from the U.S. Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323). The five-year award, running from August 1, 2024 to July 31, 2029, will support 16 projects and programs to enhance PRDOH's epidemiology and laboratory capacity for detecting, responding to, preventing, and controlling infectious diseases in...
This $4,268,000 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Investigations and Technical Assistance program (CFDA 93.283) will support the African Field Epidemiology Network LTD (AFENET) in implementing the REINFORCING IMMUNIZATION SYSTEMS FOR CONSEQUENTIAL GEOGRAPHIES (RISE4CGS) project in the Democratic Republic of Congo, Ethiopia, and Nigeria. This 5-year project, running from September 30, 2024 through September 29, 2029, aims to strengthen...
The Cooperative Agreement award of $4,989,475.00 from the Centers for Disease Control and Prevention (CDC) under the Capacity Building Assistance (CBA) for High-Impact HIV Prevention program (CFDA 93.834) supports the Latino Commission On Aids Inc., a non-profit organization in New York, NY. The award, with a performance period from August 2024 to March 2029, will enable the organization to provide a range of services to build the capacity of healthcare organizations, community-based...
This $880,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CFDA 93.283 - CDC Investigations and Technical Assistance) to Emory University will advance public health institute capabilities within the Global Network over a 5-year period from September 2024 to September 2029. The award will leverage Emory University's extensive expertise in biomedical research, public health, and infectious disease studies to support research, surveillance, epidemiological...
This $2,904,476 Cooperative Agreement award from the Centers for Disease Control and Prevention's Tribal Public Health Capacity Building and Quality Improvement Umbrella Cooperative Agreement (CFDA 93.772) program aims to enhance the capacity of the Pennsylvania Department of Health to effectively detect, respond, prevent, and control known and emerging infectious disease threats. The key objectives are to strengthen epidemiologic capacity, enhance laboratory capacity, improve public health...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $170,000 five-year Cooperative Agreement to the Universidad Del Valle De Guatemala (UVG), a private non-profit educational institution in Guatemala. The grant, funded under the CDC's Investigations and Technical Assistance program (CFDA 93.283), supports integrated surveillance and response efforts for emerging infectious diseases in Central America. The award aims to strengthen public health...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $2,688,933 cooperative agreement under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) to The Task Force for Global Health, Inc., a non-profit organization based in Decatur, Georgia. This 5-year award, effective August 1, 2024 through July 31, 2029, supports the organization's work in global health research, disease surveillance, and health systems strengthening. The Task Force...
This $4,428,000.00 Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421), supports the establishment of a Regional Center for Public Health Preparedness and Response in Region 2. The award, with a period of performance from September 30, 2024 to September 29, 2029, will enable The Trustees of Columbia...